Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-03-08
2011-03-08
Habte, Kahsay T (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S008000
Reexamination Certificate
active
07902186
ABSTRACT:
Compounds of the formula (I), in which R1, R2, m, Q and B have the meanings indicated in Claim1, are inhibitors of tyrosine kinases, in particular Met kinase, and can be employed, inter alia, for the treatment of tumours.
REFERENCES:
patent: 5747489 (1998-05-01), Jonas et al.
patent: 5859008 (1999-01-01), Jonas et al.
patent: 6596772 (2003-07-01), Huang et al.
patent: 7534785 (2009-05-01), Schadt et al.
patent: 2004/0235845 (2004-11-01), Eggenweiler et al.
patent: 2004/0259863 (2004-12-01), Eggenweiler et al.
patent: 2006/0074113 (2006-04-01), Murakata et al.
patent: 196 04 388 (1997-08-01), None
patent: 101 50 517 (2003-04-01), None
patent: 0 723 962 (1996-07-01), None
patent: 0 763 534 (1997-03-01), None
patent: 1 454 903 (2004-09-01), None
patent: WO 03/037349 (2003-05-01), None
Blaukat Andree
Dorsch Dieter
Schadt Oliver
Schultz Melanie
Habte Kahsay T
Merck Patent GmbH
Millen White Zelano & Branigan P.C.
LandOfFree
Substituted 5-phenyl-3,6-dihydro-2-oxo-6H-1,3,4-thiadiazines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 5-phenyl-3,6-dihydro-2-oxo-6H-1,3,4-thiadiazines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 5-phenyl-3,6-dihydro-2-oxo-6H-1,3,4-thiadiazines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2759643